ABX1100
Glycogen Storage Disease Due To Acid Maltase Deficiency, Late-Onset
Explore 12 assets in Glycogen Storage Disease Due To Acid Maltase Deficiency, Late-Onset →Aro BiotherapeuticsUNKNOWNEarly Phase 1
—
Rating in progress
ABX1100 in Glycogen Storage Disease Due To Acid Maltase Deficiency, Late-Onset is in the Floatz rating universe. The engine has not yet published a v0.2 rating for this asset. This page will update automatically once scoring completes.
Methodology v0.2 · Active